1Kruit MC, van Buchen MA, Hofman PA, et al. Migraine as a risk factor for subclinical brain lesions[J]. JAMA, 2004, 291 (4): 427-434.
2Stewart WF, Lipton RB, Celentano DD, et al. Prevalence of migraine headache in the United States. Relation to age, income, race, and other sociodemographic factors [J]. JAMA, 1992, 267(1): 64-69.
5Cao Y, Welch KM, Aurora S, et al. Functional MRI-BOLD of visually triggered headache in patients with migraine [J].Arch Neurol, 1999, 56(5): 548-554.
6Gagos A. Migraine with a combination of aura symptoms as a chnical manifestation of cortical spreading depression [ J ]. Neurol Neurochir Pol, 2005, 39(2): 163-165.
7Lance JW. Current concepts of migraine pathogenesis [J]. Neurology, 1993, 43(6 Suppl 3): S11-15.
8Buzzi MG, Moskonitz MA. The pathophysiology of migraine: year 2005 [J]. Headache Pain, 2005, 6(3): 105-111.
9Dzialek E, Niewodniczy A, Opacka J, et al. Diurnal rhythm of the bioelectrical activity of the brain and blood serotonin level in patients with migraine[J]. Neurol Neurochir Pol, 1983, 17(1): 63-69.
10Raskin NH. Serotonin receptors and headache [J]. N Engl Med, 1991, 325(5): 353-354.
